Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/04/2012EP1487805B1 Pyrimidine derivatives
07/04/2012EP1485094B1 Dosage form for oral administration of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester or its salts
07/04/2012EP1461047B1 Compositions and methods for animal treatment
07/04/2012EP1439858B1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
07/04/2012EP1349580B2 Process to improve stability of a pharmaceutical composition
07/04/2012EP1051174B2 Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations
07/04/2012CN202288921U Compound naproxen esomeprazole tablet
07/04/2012CN202287453U Traditional Chinese Medicinal pillow for treating cervical spondylosis
07/04/2012CN1993313B Antibiotic compound
07/04/2012CN1964965B Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
07/04/2012CN1964736B Dalbavancin compositions for treatment of bacterial infections
07/04/2012CN1962641B Metalloproteinase inhibitors
07/04/2012CN1953965B Novel cis-imidazolines
07/04/2012CN1907967B Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
07/04/2012CN1907293B Combined medicine for treating lpneumonia and preparing process thereof
07/04/2012CN1901901B Taxoid-fatty acid conjugates and pharmaceutical compositions thereof
07/04/2012CN1893827B Silver dihydrogen citrate compositions comprising a second antimicrobial agent
07/04/2012CN1882687B Method of growing myocardial cells
07/04/2012CN1882354B 细胞因子调节剂及相关用法 Cytokines regulate agents and related usage
07/04/2012CN1874777B 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
07/04/2012CN1857497B Erosion treating Chinese medicine ointment and its quality control method
07/04/2012CN1845911B Condensed ring compound and use thereof
07/04/2012CN1832928B 5-membered heterocycle-based p38 kinase inhibitors
07/04/2012CN1809557B Compound
07/04/2012CN1791592B 免疫抑制剂化合物和组合物 Immunosuppressive compounds and compositions
07/04/2012CN1713897B Sustained release preparation
07/04/2012CN1668613B Flavone derivatives of inhibitors of cyclin-dependent kinases
07/04/2012CN1536986B Intravaginal drug delivery devices for administration of antimicrobial agent
07/04/2012CN1503796B Polymorphic and other crystalling forms of cis-ftc
07/04/2012CN1449386B Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
07/04/2012CN1338939B Compositions for the treatment of male erectile dysfunction
07/04/2012CN102549158A Treatment of transcription factor E3 (TFE3) and insulin receptor substrate 2 (IRS2) related diseases by inhibition of natural antisense transcript to TFE3
07/04/2012CN102549153A Prophylactic and/or therapeutic agent for metabolic syndrome
07/04/2012CN102549152A Adenoviral-based vectors
07/04/2012CN102549007A Method for making 3alpha-hydroxy, 3beta- methyl-5alpha-pregnan-20-one (ganaxolone)
07/04/2012CN102549005A Method for the preparation of a crystalline form of 1-chloro-4- (beta-d-glucopyranos-1-yl)-2-(4-((s)-tetrahydrofuran-3-yloxy)benzyl)benzene
07/04/2012CN102549000A Fused thiazolo and oxazolo pyrimidinones
07/04/2012CN102548995A Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
07/04/2012CN102548993A Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals
07/04/2012CN102548992A 2, 7 -naphthyridin- 1 -one derivatives as syk kinase inhibitors
07/04/2012CN102548991A Imidazopyridine or imidazopyrimidine derivatives as phosphodiesterase 10A inhibitors
07/04/2012CN102548990A Inhibitors of phosphatidylinositol 3-kinase
07/04/2012CN102548989A Sphingosine-1-phosphate receptor agonists
07/04/2012CN102548987A Fluoro-substituted compounds as kinase inhibitors and methods of use thereof
07/04/2012CN102548986A Aminopyrrolidinone derivatives and uses thereof
07/04/2012CN102548985A Substituted carbonyl compounds
07/04/2012CN102548984A Inhibitors of PI3 kinase and / or MTOR
07/04/2012CN102548983A Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
07/04/2012CN102548982A Azetidinyl diamides as monoacylglycerol lipase inhibitors
07/04/2012CN102548977A Sulfone derivative
07/04/2012CN102548976A (Thio) morpholine derivatives as S1P modulators
07/04/2012CN102548975A Histone deacetylase inhibitors
07/04/2012CN102548974A Novel FXR (NR1H4 ) binding and activity modulating compounds
07/04/2012CN102548971A Crystalline form i rosuvastatin zinc salt
07/04/2012CN102548970A Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as AKT (PKB) phosphorylation inhibitors
07/04/2012CN102548965A 取代酰胺化合物 Substituted amide compounds
07/04/2012CN102548964A Etomidate analogues that do not inhibit adrenocortical steroid synthesis
07/04/2012CN102548963A Novel N-substituted-pyrrolidines as inhibitors of MDM2-p53 interactions
07/04/2012CN102548945A Apogossypolone derivatives as anticancer agents
07/04/2012CN102548629A Improved purification of multi-specific receptors
07/04/2012CN102548579A Dosage regimen of an s1p receptor modulator
07/04/2012CN102548572A Vaccines and compositions against streptococcus pneumoniae
07/04/2012CN102548567A Composition comprising curcuma longa extract together with curcuma zedoaria extract
07/04/2012CN102548562A Ophthalmic composition
07/04/2012CN102548561A Ethyleneoxide butyleneoxide block copolymer compositions
07/04/2012CN102548560A Compositions and methods for prevention and treatment of coronary heart diseases
07/04/2012CN102548559A Composition for the treatment of cystic fibrosis
07/04/2012CN102548558A Novel aminopyridine derivatives having Aurora A selective inhibitory action
07/04/2012CN102548557A Compounds for the reduction of beta-amyloid production
07/04/2012CN102548556A Tablet
07/04/2012CN102548555A Compositions and methods for treating parkinson's disease
07/04/2012CN102548554A Method for treating Th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor
07/04/2012CN102548553A Method and composition for treating diabetic ketoacidosis
07/04/2012CN102548552A Spectinamides as anti-tuberculosis agents
07/04/2012CN102548551A Derivatives of N-hydroxybenzamide for treating HIV infections
07/04/2012CN102548550A Exo-S-mecamylamine method, use, and compound for treatment
07/04/2012CN102548549A Methods for treatment of a sarcoma using an epimetabolic shifter (Coenzyme Q10)
07/04/2012CN102548548A Pharmaceutical composition for use in medical and veterinary ophthalmology
07/04/2012CN102548547A Soluble pharmaceutical forms of N,N'-diaminodiphenyl sulphone for optimum use in the treatment of various diseases
07/04/2012CN102548546A Transdermal therapeutic system for administering fentanyl or an analogue thereof
07/04/2012CN102548543A Slow-release cilostazol tablet having an improved elution rate and minimal side effects
07/04/2012CN102548542A Tablet that disintegrates rapidly in the mouth and that contains two or more types of particles
07/04/2012CN102548540A Solid pharmaceutical preparations comprising amphiphilic copolymers on the basis of polyethers in combination with surfactants
07/04/2012CN102548539A Pharmaceutical compositions for the treatment of cancer and other diseases or disorders
07/04/2012CN102548538A Topical formulation for diabetic foot ulcers
07/04/2012CN102548537A Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate
07/04/2012CN102548536A Olopatadine compositions and uses thereof
07/04/2012CN102548535A Sublingual and buccal film compositions
07/04/2012CN102548530A 黑色素产生抑制剂 Melanin production inhibitor
07/04/2012CN102548529A Collagen production accelerating composition
07/04/2012CN102548417A Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
07/04/2012CN102548407A The use of metabotropic glutamate receptor potentiators for reducing nicotine dependence
07/04/2012CN102548406A Process for the synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5'7'-tetraiodo-3h-spiro[isobenzofuran-1,9'-xanthen]-3-one (rose bengal) and related xanthenes
07/04/2012CN102539466A Method for screening medicament for treating brain injury
07/04/2012CN102533996A Method for determining APRIL (A Proliferation-inducing Ligand) gene promoter and transcription factor binding site and use
07/04/2012CN102533600A Marine streptomyces/pyranosesquiterpene compound and preparation method and application thereof
07/04/2012CN102533588A Lactobacillus brevis for producing extracellular exopolysaccharide and application thereof
07/04/2012CN102532341A Extraction method and application of chroogomphus rutilus polysaccharide
07/04/2012CN102532339A Method for selenizing pilose asiabell root polysaccharides and application of product
07/04/2012CN102532263A Bi-component drug micromolecule hydrogel based on hexadecadrol and taxol and preparation method thereof